Those reports indicate that targeting the regulatory SNHG16/miR-195/PCMT1 axis could serve as a promising therapeutic target for patients with breast cancer.9 PCMT1 regulated the proliferation, apoptosis, and migration of various cells (Fig. 6). This evidence concerns the gene PCMT1 and breast cancer.